School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, China.
Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on the Chronic Inflammation, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Oxid Med Cell Longev. 2020 Jul 4;2020:1364147. doi: 10.1155/2020/1364147. eCollection 2020.
(AM), used in traditional Chinese medicine, has been shown to enhance immune functions, and recently, its anti-inflammatory effects were identified. However, the mechanisms of action remain unclear. Most studies have shown that autophagy might be involved in the immune response of the body, including inflammation. Here, we developed an inflammatory model by stimulating macrophages with lipopolysaccharides (LPS) to explore the anti-inflammatory effect and mechanisms of AM injection from the perspective of the regulation of autophagy. Immunoblot, immunofluorescence, and ELISA were used to determine the effects of AM injection on the production of interleukin-6 (IL-6) and alterations of autophagy markers. It was found that AM injection reduced the expression of IL-6 in LPS-stimulated macrophages and reversed the LPS-induced inhibition of cellular autophagy. After treatment with inhibitors of signaling pathways, it was shown that LPS downregulated autophagy and upregulated the production of IL-6 in macrophages via the protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway. AM injection reversed the effects of LPS by activating the AMP-activated protein kinase (AMPK) instead of inhibiting Akt. These results were further confirmed by testing activators and siRNA silencing of AMPK. Hence, these 2 distinct signaling molecules appear to exert opposite effects on mTOR, which integrates information from multiple upstream signaling pathways, negatively regulating autophagy. In addition, we demonstrated that autophagy might play a key role in regulating the production of IL-6 by testing activators and inhibitors of autophagy and siRNA silencing of . These findings showed that AM injection might enhance autophagy by activating AMPK and might further play a repressive effect on the LPS-stimulated expression of IL-6. This study explored the relationship between autophagy, signaling pathways, and the production of inflammatory factors in a model of endotoxin infection and treatment with AM injection.
(AM)在中药中被应用,已被证明可增强免疫功能,最近,其抗炎作用也被确定。然而,其作用机制尚不清楚。大多数研究表明,自噬可能参与了机体的免疫反应,包括炎症。在这里,我们通过用脂多糖(LPS)刺激巨噬细胞来建立炎症模型,从自噬调节的角度探讨 AM 注射的抗炎作用和机制。免疫印迹、免疫荧光和 ELISA 用于确定 AM 注射对白细胞介素 6(IL-6)产生的影响和自噬标志物的变化。结果发现,AM 注射可降低 LPS 刺激的巨噬细胞中 IL-6 的表达,并逆转 LPS 诱导的细胞自噬抑制。在用信号通路抑制剂处理后,结果表明 LPS 通过蛋白激酶 B(Akt)/哺乳动物雷帕霉素靶蛋白(mTOR)通路下调自噬并上调巨噬细胞中 IL-6 的产生。AM 注射通过激活 AMP 激活蛋白激酶(AMPK)而不是抑制 Akt 来逆转 LPS 的作用。这些结果通过测试 AMPK 的激活剂和 siRNA 沉默进一步得到证实。因此,这 2 种不同的信号分子似乎对整合来自多个上游信号通路的信息的 mTOR 产生相反的作用,负调节自噬。此外,我们通过测试自噬的激活剂和抑制剂以及 的 siRNA 沉默,证明自噬可能在调节 IL-6 产生中发挥关键作用。这些发现表明,AM 注射可能通过激活 AMPK 增强自噬,并可能进一步对 LPS 刺激的 IL-6 表达产生抑制作用。本研究探讨了自噬、信号通路与内毒素感染模型中炎症因子产生及 AM 注射治疗之间的关系。